Literature DB >> 8632685

Using health status measures with the seriously mentally ill in health services research.

B Dickey1, H Wagenaar, A Stewart.   

Abstract

Changes in the delivery of mental health care have prompted interest in using generic health status measures to test the effect of system change on those receiving treatment. Of special concern are those with serious and persistent mental illness who may be neglected when cost containment efforts reduce the availability of treatment services. This population may be affected by these changes, which might go undetected if investigators use scales that measure only pathology and not the full spectrum of well-being. The purpose of this study was to test the feasibility of using self-report health status measures with this population, to describe the psychometric properties of the scales, and to report the health status scores of a random sample of the Medicaid psychiatrically disabled population. We found that the four health status scales had adequate psychometric properties, that score variability was high, the distributions normal, and that patterns of association with more traditional clinical measures were of the expected size and direction. One scale, General Health Perceptions, had reliability and item-to-score correlation below acceptable levels.

Entities:  

Mesh:

Year:  1996        PMID: 8632685     DOI: 10.1097/00005650-199602000-00003

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  5 in total

1.  Statewide replication of predictive validation for the Multnomah Community Ability Scale.

Authors:  B Zani; B McFarland; M Wachal; S Barker; N Barron
Journal:  Community Ment Health J       Date:  1999-06

2.  Are Single-Item Global Ratings Useful for Assessing Health Status?

Authors:  Cathaleene Macias; Paul B Gold; Dost Öngür; Bruce M Cohen; Trishan Panch
Journal:  J Clin Psychol Med Settings       Date:  2015-10-22

3.  The cost and outcomes of community-based care for the seriously mentally ill.

Authors:  B Dickey; W Fisher; C Siegel; F Altaffer; H Azeni
Journal:  Health Serv Res       Date:  1997-12       Impact factor: 3.402

4.  Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.

Authors:  D A Revicki; L A Genduso; S H Hamilton; D Ganoczy; C M Beasley
Journal:  Qual Life Res       Date:  1999-08       Impact factor: 4.147

Review 5.  A history of health-related quality of life outcomes in psychiatry.

Authors:  Dennis A Revicki; Leah Kleinman; David Cella
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.